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GENERAL INTRODUCTION 
The concept of exercise performance has commonly challenged the 
highest abilities of the athlete as the performer, and of the exercise 
physiologist as the evaluator of the athlete's performance. In addi-
tion, researchers have investigated the use of various ergogenic aids 
that may alter the physiological processes. The results and conclusions 
of such investigations have added greatly to the body of knowledge as 
it relates to physical performance. 
Caffeine is classified as a mild stimulant and euphoriant. It is 
through these characteristics that .caffeine exerts its effects on various 
systems of the human body. Direct stimulation of the cerebral cortex 
and enhanced secretion of the catecholamine epinephrine results from 
caffeine administration (18). Stimulation of cardiac muscle by caffeine 
has been shown to influence heart rate as well as changes in electro-
cardiographic activity. The myocardial stimulation and various influ-
ences on vasomotor tone due to caffeine ingestion have been shown to 
alter resting blood pressures (20). Caffeine administration decreases 
vital tubular reabsorption of sodium (Na+) and increases the glomerular 
filtration rate, leading to a diuretic effect (18). Caffeine may also 
cause an increase in metabolic heat propuction through a stimulation 
of the thermoregulatory functions of the hypothalamus (26). 
While the general stimulatory effect of caffeine taken in smaller 
dosages (less than 200 mg) is known to overcome fatigue and drowsiness 
and improve mental concentration for extended periods, larger caffeine 
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dosages (more than 500 mg) may cause such side effects as the impairment 
of motor function, nervousness, irritability, insomnia, tachycardia, 
and cardiac arrhythmias (18). The diuretic effect of caffeine adminis-
tration may promote a state of hypohydration (2). 
The use of caffeine and its effect on exercise performance has pre-
sented an element of physiological interest in \'Jhich controversy has 
often been the result. Administration of caffeine is known to increase 
plasma free fatty acid levels through the activation of cyclic AMP 
(cA~1P). Cyclic AMP activates triglyceride lipases, which hydrolise tri-
glycerides in adipose tissue and increase the levels of free fatty acids 
circulating in blood plasma (18). It has been suggested that an eleva-
tion in plasma free fatty acids is associated with an increase in the 
utilization of fats and a diminished use of carbohydrates as an energy 
source for muscular work during prolonged exercise (8). Since the deple-
tion of carbohydrate stores, in the form of muscle and liver glycogen, 
and a decrease in blood glucose levels are associated with muscular fa-
ti gue, a "spari ng" of carbohydrates through an increase in fatty aci d 
metabolism may prolong exercise duration (8, 17). Although improvement 
in exercise performance with the ingestion of caffeine has been demon-
strated, it has, as yet, to be universally accepted. 
Caffeine has known effects on the nervous, respiratory, cardiovas-
cular, and thermoregulatory systems. However, little research is avail-
able on the specific effects of these systems to caffeine administration 
with exercise. It is common knowledge that as the human body progresses 
from a resting state to an active state specific physiological changes 
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must take place in order to meet the increased metabolic demands of the 
body. Such changes are largely mediated through neural responses. Heart 
rate, blood pressure, ventilation, and the regulation of heat production 
are all physiological processes that generally parallel changes in human 
activity levels. Whether or not the ingestion of caffeine, with the 
intent of improving exercise performance, simultaneously influences hemo-
dynamic, respiratory, or thermoregulatory responses to exercise so as 
to beneficially or adversely affect performance is a question that is 
yet to be answered. 
Statement of the Problem 
It was the purpose of this investigation to: 1) observe changes 
in the cardiovascular response pattern (heart rate, blood pressure, elec-
trocardiographic activity) during maximal and submaximal exercise re-
sulting from caffeine ingestion and 2) to determine the effects of caf-
feine ingestion on heat stress during submaximal exercise as determined 
by blood constituents (hemoglobin, hematocrit, serum sodium (Na+) and 
potassium (K+) and body temperatures) on healthy untrained males ages 
21-28. 
Hypotheses 
With the administration of caffeine serving as the experimental 
trial and the administration of the placebo as the control trial, the 
following hypotheses were tested by appropriate statistical procedures: 
1. No significant differences will be found between control and experi-
mental trials in heart rate and blood pressure responses during 
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maximal or submaximal exercise. 
2. There will be no change in electrocardiographic activity between 
control and experimental trials during maximal or submaximal exer-
cise. 
3. Body temperature will exhibit no significant difference between 
control and experimental trials during submaximal exercise. 
4. Serum electrolyte levels (Na+, K+) and hematological constituents 
(hemoglobin, hematocrit) will not change significantly between con-
trol and experimental trials during submaximal exercise. 
5. There will be no Significant differences between control and experi-
mental trials in urinary output before and after exercise in the 
submaximal work bouts. 
6. Respiratory or metabolic parameters (minute ventilation, oxygen 
consumption, respiratory exchange ratio) will not change signifi-
cantly between control and experimental trials during maximal or 
submaximal exercise. 
L imitati ons 
Each subject was instructed to keep caffeine consumption and die-
tary habits consistent throughout the course of the investigation. HOV/-
ever, because the dietary control was voluntary and conducted outside 
of the laboratory setting, it may only be assumed that such control Has 
rigidly followed. 
Assays were not conducted in this study to determine caffeine con-
centrations in blood. According to previous research, peak blood 
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caffeine concentration occurs approximately one hour post-ingestion. 
It was assumed that the subjects in the present investigation exhibited 
peak caffeine concentration levels at this same time period. 
Delineations 
The subjects used in this investigation were all volunteers respond-
ing to advertised notices. All subjects were either students at Iowa 
State University or residents of the Ames, Iowa community. 
Justification 
Caffeine has been widely used by individuals competing in endurance 
activities, such as running and cycling~ with the belief that this sub-
stance may benefit performance. However, the known effects of caffeine 
on such physiological processes as heart rate, blood pressure, electro-
cardiographic responses, and thermoregulation may be such during pro-
longed activity that performance may actually be impaired. In addition, 
the effects of caffeine on cardiovascular responses may also prove detri-
mental to maximal exercise performance. Due to a lack of available infor-
mation focusing on the specifics of cardiovascular and thermoregulatory 
adaptations to exercise as influenced by caffeine ingestion, as well 
as the possible adverse effects of caffeine and exercise to an individ-
ual's physical health, this investigation was designed and conducted 
with the belief that the data gathered may provide insight into questions 
concerning the use of a popular substance on exercise performance that 
have yet to be addressed. 
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Explanation of Thesis Format 
This thesis follows the optional or alternate thesis format \'Ihich 
includes two papers intended for submission to the Journal of Applied 
Physiology and as such, utilized the style of manuscript required by 
that publication. A general introduction, review of pertinent litera-
ture, and general summary were included to meet graduation requirements 
at Iowa State University. The additional review of literature, in ex-
panded form, necessitated an additional list of literature citations 
which should not be confused with citations within the individual pa-
pers. 
Human Subjects Statement 
The Iowa State University Committee on the Use of Human Subjects 
in Research reviewed this project and concluded that the rights and wel-
fare of the human subjects were adequately protected, that risks were 
outweighed by the potential benefits and expected value of the knowledge 
sought, that confidentiality of data was assured and that informed con-
sent was obtained by appropriate procedures. 
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REVIEW OF LITERATURE 
The use of caffeine and its effect on physiological functions dur-
ing exercise has been widely studied due to a possible role in promoting 
the mobilization and utilization of free fatty acids as an energy source 
during prolonged exercise. Although the effects of caffeine on the 
cardiovascular, thermoregulatory, nervous, and other systems have been 
documented under resting conditions, the purpose of this review was 
to summarize information on the effects of caffeine on the forementioned 
systems during exercise. 
Van Handel et ale (26) examined the effects of various caffeine 
dosages (0, 22.5, 35, and 150 mg) administered in a 10 oz. decaffeinated 
cola solution on heart rate and blood pressure responses in six men 
and six women volunteers (20-42 years) during a six-hour resting state. 
Blood pressure values were reported as pulse pressure (PP=systolic blood 
pressure - diastolic blood pressure) and mean arterial pressure (MAP 
= 1/3 pulse pressure + diastolic pressure). Pulse pressure exhibited 
a significant (p < .05) decrease of 4 to 5 mm Hg (no actual values re-
ported) during the first 15 minutes following ingestion of each of the 
assigned solutions and then remained relatively stable throughout the 
rest of the trial. No significant differences were observed due to 
differences in caffeine concentration levels. Mean arterial pressure 
increased significantly (p < .05) during the first 30 minutes after 
ingestion of the 150 mg solution only, and remained elevated throughout 
the end of the trial (no values reported). Nonsignificant increases 
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of ~~p of lesser magnitude were observed for the 22.5 and 35 mg solu-
tions, as compared to the 150 mg solution 30 minutes post-ingestion. 
Throughout the six hour period, mean arterial pressure remained at pre-
ingestion levels for the 0 mg solution. 
Heart rate decreased significantly (p < .05) by approximately six 
beats/minute during the first 30 minutes from pre-ingestion values (mean 
of 62 to 56 beats/min.) for all solutions and remained stable until the 
end of the trial. No significant differences (p > .05) for the heart 
rate were reported between solutions at any point during the experiment. 
Heart rate response as an indicator of tolerance to caffeine-
mediated cardiovascular effects was examined by Cotton (8). A total 
of 149 subjects (138 males, 11 females; no ages reported) were used 
and each was assigned to one of two categories (coffee drinker or non-
coffee drinker). The noncoffee drinkers were classified as those con-
suming not more than one serving of a caffeinated beverage per day, 
while all others were classified as coffee drinkers. The caffeine solu-
tion consisted of 150 mg of powdered caffeine added to decaffeinated 
coffee. The placebo solution consisted of decaffeinated coffee with 
150 mg of powdered lactose added. Subjects were instructed to record 
heart rate measurements at their normal bedtime in the following man-
ner: 3 times at 5 minute intervals before and 30 to 40 minutes after 
ingestion of the assigned solution. Caffeine-induced bradycardia (a 
decrease in resting heart rate> 5 beats/min.) was experienced in a 
significantly (p < .05) larger percentage of the noncoffee drinkers 
(41%) as compared to the coffee drinkers (23%). No significant 
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differences in the occurrence of bradycardia were experienced between 
groups following administration of the placebo solution. The occurrence 
of tachycardia (increase in resting heart rate> 5 beats/min.) was not 
significant for either group or bet~leen groups following ingestion of 
either solution. No actual heart rate values were reported. Individual 
acquired tolerance to the effects of a mild dosage of caffeine was of-
fered as an explanation for the lower incidence of bradycardia experi-
enced by the coffee group as compared to the noncoffee group. No spe-
cific time period was suggested as necessary to acquire such a toler-
ance. 
Robertson et al. (24) studied heart rate, blood pressure, and res-
piratory rate during rest to determine the influence of caffeine inges-
tion. Nine subjects (6 males, 3 females, 21-30 years) ingested either 
a caffeine (250 mg) or a placebo (1 gm Pero rye-barley extract) solution 
and were tllen instructed to rest in a supine position for three hours. 
Heart rate and blood pressure were recorded at 15 minute intervals dur-
ing the trial periods, and respiratory rate Has measured for a 10 minute 
period one hour after ingestion of each solution. Blood pressure ex-
hibited a significant (p < 0.05) increase in the caffeine trial compared 
to the placebo trial, with maximum mean increases of 14 mm Hg systolic 
pressure and 10 mm Hg diastolic pressure (no actual values were reported 
for blood pressure readings) occurring one hour post-ingestion. Both 
systolic and diastolic blood pressures for the caffeine trial remained 
significantly (p < 0.05) elevated above placebo trial blood pressure 
values throughout the three-hour period. A significant (p < 0.05) 
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decrease in heart rate (5 beats/minute) was observed 45 minutes follow-
ing the ingestion of caffeine. This decrease in heart rate lasted for 
approximately one hour. Thereafter, heart rate increased significantly 
(p < 0.05) from 60 beats/minute to 70 beats/minute in the caffeine trial 
and remained elevated for the duration of the experimental period. No 
significant changes in heart rate were observed in the placebo trial. 
The authors noted that the period of maximum decline in heart rate corre-
sponded with the period of greatest blood pressure elevation. Respira-
tory rate measured one hour post- ingestion was significantly (p < 0.05) 
greater in the caffeine trial (16.1±2.3 breaths/min.) compared to the 
placebo trial (13.4±1.6 breaths/min.). No further respiratory measures 
were reported. 
Bertrand et al. (5) reported data from a 10-year longitudinal study 
(1968-1978) conducted by the International Business Ivtachines Corporation 
(IBM) in which no specific relation between daily caffeine consumption 
and blood pressure elevation was observed. Data were gathered from 
72,101 IBM employees. Physiological variables recorded were resting 
heart rate, blood pressure, electrocardiogram, and caffeine consumption 
habits during this la-year period. A large majority of the subjects 
(95%) exhibited resting systolic blood pressure <140 mm Hg and resting 
diastolic blood pressure <90 mm Hg regardless of caffeine consumption 
habits. Data in this investigation were published in response to the 
forementioned study by Robertson et al. in which clinical concerns for 
hypertensive patients who were also heavy caffeine consumers were pro-
posed. The authors in the present study suggested that caffeine 
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consumption habits did not appear to correlate highly with the incidence 
of hypertension. However, the authors recommended further longitudinal 
studies be conducted on caffeine consumption habits of individuals de-
fined as clinically hypertensive. 
Gould et ale (15) examined the effects of caffeine on resting heart 
rate and blood pressure in 15 subjects with normal or abnormal cardiac 
function. Five of the subjects were classified as having normal cardiac 
function and 10 subjects had identifiable heart disease. Each subject 
drank 6 oz. of hot water containing 158 mg of caffeine. Heart rate 
and blood pressure measurements were recorded 20 minutes following in-
gestion of the caffeine. No significant (p < 0.05) changes in resting 
heart rate or blood pressure were observed in either group. Actual 
values for heart rate and blood pressures for either group were not 
reported. The authors concluded that caffeine ingested in small amounts 
(at least not in excess of the dosage in this study) appears to be safe 
for cardiac patients. 
In addition to its influence on heart rate and blood pressure, 
caffeine has been indicated as a possible cause of cardiac arrhythmias, 
most notably pre-ventricular contractions. The onset of arrhythmic 
activity has traditionally led many investigators to link the use of 
caffeine to an increase in the risks of sudden heart attacks. 
In the forementioned study by Gould et al., subjects were monitored 
for changes in electrocardiographic activity following ingestion of 
the caffeine solution (158 mg). A standard 12 lead resting electro-
cardiogram was used. The occurrence of arrhythmias produced by caffeine 
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were not found in any of the subjects with either normal or abnormal 
cardiac function. 
Dobmeyer et al. (11) performed a recent investigation to determine 
the effects of caffeine administration on cardiac electrical activity. 
Seven volunteers (20-31 years) with normal cardiac function and 12 car-
diac patients (17-61 years) were monitored for the occurrence of arrhyth-
mic activity after oral ingestion of caffeinated coffee (200 mg caf-
feine) or intravenous caffeine (200 mg) administration. Catheters were 
positioned into the heart at the mid left atrium, the coronary sinus, 
the His bundle, and the right ventricular apex to monitor all electrical 
activity. In addition, arrhythmic promotion was performed and measured 
by application of an electrical stimulus to the myocardium. No signifi-
cant changes were noted in impulse conduction intervals or recovery 
time periods in either group regardless of the method of caffeine admin-
istration. Effective refractory periods for impulse conduction were, 
however, significantly (p < 0.05) shortened or lengthened, depending 
on the respective recording site, in both groups. Changes in refractory 
periods were not significant regardless of the method of caffeine admin-
istration. Specific length of the observed refractory period time inter-
vals were not reported. Application of the extra stimuli produced ven-
tricular tachycardia following caffeine ingestion in two of the cardiac 
patients and in none of the normal subjects. Supraventricular arrhyth-
mias (atrial flutter-fibrilation, supraventricular tachycardia) follow-
ing extrastimulus and caffeine ingestion were reported in three of the 
normal subjects and in six of the cardiac patients. Observed 
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ventricular and supraventricular arrhythmias were apparently the same 
regardless of the method of caffeine administration. Atrial flutter-
fibrilation was recorded in two normal subjects and one cardiac patient 
when the extrastimulus was applied without ingesting caffeine. The 
conclusion was drawn from this investigation that the incidence of ar-
rhythmic activity observed, primarily in the cardiac patients, should 
pose questions and further research on the use of caffeine by those 
individuals known to be most susceptible to possible adverse effects 
of caffeine. 
Mathieu et al. (20) conducted a study on the association of arrhyth-
mogenic occurrence and caffeine consumption habits. Subjects were 113 
volunteers (no age or sex distributions were reported) who were classi-
fied as heavy caffeine consumers (>5 cups coffee/day). Each subject 
ingested 300 mg of caffeine and was monitored for changes in resting 
electrocardiogram one hour post-ingestion. Tachycardia (increase in 
heart rate> 5 beats/min.) occurred in 24 subjects, while 7 subjects 
experienced bradycardia (decrease in heart rate < 5 beats/min.). No 
other arrhythmias were reported. Further research comparing the effects 
of various caffeine dosages and caffeine consumption habits was sug-
gested. 
The effect of caffeine on the renal system has been well document-
ed. The decrease in renal tubular reabsorption of sodium (Na+) and 
water, and increase in the glomerular filtration rate produced by caf-
feine administration has been shown to lead to a pronounced diuretic 
effect. An increased body fluid loss through induced diuresis is known 
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to have a marked effect on hypohydrati on. In addition to its abi 1 ity 
to enhance fluid losses, caffeine is known to influence heat production 
through stimulation of thermoregulatory centers within the hypothala-
mus. The following section of this review will examine possible effects 
on human thermoregulatory processes as determined by caffeine adminis-
tration, as both a diuretic and heat-producing substance. 
Bellet et al. (3) measured total urine production following caf-
feine ingestion in a resting data study. Eighteen males (18-22 years) 
ingested either a caffeine solution (220 mg caffeine in 500 ml water) 
or a control solution (500 ml water) and then sat for three hours. 
Urine samples were collected during the test period to determine total 
urine production. The ingestion of the caffeine solution produced a 
mean urine volume of 496.5 ml. Mean urine volume for the caffeine trial 
was significantly (p < 0.01) greater than mean urine volume for the 
control trial (325.8 ml). 
Robertson et al. (24) examined urinary electrolyte concentrations 
(Na+, K+) in three female and six male subjects (21-30 years) following 
the ingestion of either 250 mg caffeine in 300 ml water or a placebo 
of 300 ml water. Subjects were maintained in a resting state for 3 
hours. Urine excretion volume for the caffeine trial was significantly 
(p < 0.05) greater than urine volume for the placebo trial (469±43 ml 
to 366±30 ml, respectively). In addition, urinary Na+ excretion was 
greater (p < 0.05) following caffeine ingestion (16.4±2.4 m Eq) than 
following ingestion of the placebo (14.4±2.5 m Eq). No significant 
differences, however, were found between solutions for urinary K+ 
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excretion. 
The di ureti c effect of caffei ne vias also investigated by Dorfman 
and Jarvik (12). Forty-one medical students (20-30 years) received 
300 mg of caffeine mixed in 2.5 gm of decaffeinated coffee. Each sub-
ject was instructed to collect all urine excreted during an eight hour 
period following the ingestion of caffeine. Total 'urine volume was 
determined and total urine Na+ and K+ concentration vlere measured. 
Total mean volume (386 ml) for the caffeine trial did not differ from 
the placebo trial (337 ml). There was a significant (p < 0.01) dif-
ference in Na+ excretion between the caffeine and placebo trials (54.9 
m Eq to 34.8 m Eq, respectively). 
Uager-Srdar et ale (27) studied the thermoregulation effects of 
caffeine ingestion in eight male rats by measuring colonic temperatures. 
Caffeine was administered subcutaneously in a dose of 50 mg/kg body 
weight. A saline solution was administered as the placebo. Colonic 
temperature was recorded 5, 10, 15, 20, 25, 30, 45, 60, 75, 90 and 120 
minutes after the respective solution was given. The saline placebo 
produced a slight decrease in baseline temperature that began 20 minutes 
post-administration and continued throughout the experimental period. 
However, the mean change in temperature for the placebo trial was not 
found to differ significantly from baseline. Caffeine ingestion pro-
duced an increase in temperature above baseline that began five minutes 
post-administration and persisted throughout the experiment. Contrary 
to the changes observed in the placebo trial, mean caffeine temperature 
changes were-found to be significantly (p < 0.05) different from 
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baseline. The authors did not report actual temperature values. 
In a forementioned study by Van Handel et al., urine production 
was measured following the ingestion of various caffeine dosages. Only 
the 150 mg solution produced a urine volume that was significantly 
(p < 0.05) greater than the control (0 mg) solution (430 ml to 300 ml, 
respectively). Total urine volume increased above the control volume 
for the 22.5 and 35 mg solutions, but these increases were not statis-
tically significant. In addition to total urine volume, core tempera-
ture was measured in an attempt to determine the effects of caffeine 
on heat production. Temperatures for each subject were measured every 
30 minutes during the six hour period. No significant changes were 
noted in core temperatures above pre-ingestion values for any of the 
caffeine solutions. The authors indicated that a larger dose of caf-
feine may have been required to elicit a significant increase in body 
core temperature. 
In a study by Costill et al. (7) in which metabolic responses due 
to caffeine ingestion and its effects on exercise performance were in-
vestigated, heart rates were not found to differ significantly between 
caffeine and placebo trials. Nine competitive cyclists (7 males, 2 
females) were given 330 mg of caffeine mixed with 5 gm of decaffeinated 
coffee or a placebo solution of 5 gm of decaffeinated coffee one hour 
prior to the exercise bout. All subjects were instructed to exercise 
at approximately 80% V02max until exhaustion. Heart rates for the caf-
feine trial were higher at 30 minutes (158±3 to 167±4 beats/min.), 50 
minutes (171±3 to 170±4 beats/min.) and the final collection period 
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(176±5 to 173±4 beats/min) during exercise, although none of the dif-
ferences were found to be significant. 
Ivy et al. (17) performed a similar investigation (7 male, 2 female 
trained cyclists) on the metabolic effects of caffeine and carbohydrate 
feedings during endurance exercise. Exercise consisted of two hours 
of bicycle ergometry conducted at approximately 80% of the subjects 
V02max. Three trials were assigned, with one trial serving as the con-
trol trial, one trial serving as the caffeine trial, and one trial serv-
ing as the carbohydrate trial. Two hundred and fifty mg of caffeine 
were ingested one hour prior to exercising in the caffeine trial, with 
an additional 250 mg of caffeine ingested at 15 minute intervals during 
the exercise bout. An aqueous glucose polymer solution, equivalent 
to 25% of the estimated total carbohydrate content utilized by each 
subject during a pre-experiment practice trial, served as the carbo-
hydrate solution. The control solution consisted of an artificially 
sweetened lemonade drink. Carbohydrate and control solutions were ad-
ministered immediately prior to and at 15 minute intervals during the 
first 90 minutes of exercise. Heart rate was measured at 10 minute 
intervals throughout the exercise bout. Mean heart rate for the 
caffeine trial was higher than mean heart rate values reported for the 
control and carbohydrate trials (173±1.55 to 170±1.13 and 169±1.08 
beats/min., respectively). However, the differences in heart rates 
between treatments were not found to be statistically (p < 0.05) sig-
nificant. 
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Caffeine mediated effects on exercise performance and cardiovas-
cular function were studied by Perkins and Williams (21). Fourteen 
female subjects (22.1 years) performed a standardized progressive work-
load exercise bout on a bicycle ergometer until exhaustion was reached. 
The initial workload was 300 kgm for one minute, and was increased 100 
kgm/min. until a pedalling rate of 40 RP~1 could no longer be main-
tained. Three different caffeine trials were used, with a caffeine 
dosage of 4 mg/kg body weight, 7 mg/kg body weight, and 10 mg/kg body 
weight assigned to each subject. Caffeine was dissolved in 3 oz. of 
orange juice. The placebo contained 3.5 mg/kg body v/eight sodium ci-
trate also dissolved in 3 oz. of orange juice. Solutions were ingested 
30 minutes prior to exercise. Heart rate measurements were taken prior 
to exercise (resting heart rate), during the last 15 seconds of work-
loads 300, 400 and 500 kgm (submaximal heart rate), and the last 15 
seconds prior to the cessation of exercise (maximal heart rate). No 
significant differences were noted in resting, submaximal, or maximal 
heart rates between placebo and any of the caffeine treatments. Dif-
ferences between the caffeine dosages were also not significant. 
Toner et ale (25) examined the effects of caffeine on both maximal 
and submaximal heart rate response during a discontinuous maximal exer-
cise bout. Eight males (2S±4 years) volunteered as subjects. Both 
the placebo solution (3 gm of 97% decaffeinated coffee in 230 ml of 
water) and the caffeinated solution (350 mg caffeine anhydrous in 230 
ml of water) were ingested 30 minutes before the exercise bout. The 
exercise protocol consisted of two separate trials (caffeine and 
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placebo) using a bicycle ergometer with the exercise intensity progres-
sively increased until the subject reached the exhausted state. Each 
workload lasted 5 minutes with a 10 minute rest interval. Heart rates 
were recorded during the last 15 seconds of each workload and at the 
cessation of exercise. Submaximal heart rate was determined as the 
heart rate value observed at the end of the first and second workload. 
Maximal heart rate was determined as the heart rate value recorded at 
the immediate cessation of exercise. Ingestion of the caffeine solution 
significantly (p < 0.01) increased maximal heart rate by 5 beats/min. 
compared to ingestion of the placebo solution (185 beats/min. to 180 
beats/min., respectively). However, no significant differences were 
found between trials for submaximal heart rate at either workload in-
tensity. 
Heart rates were observed by Powers et ale (22) in an investigation 
to assess the effects of caffeine on metabolism and performance during 
graded exercise. Seven male subjects volunteered to participate in 
two separate graded exercise trials on a bicycle ergometer. Workload 
intensity was initially set at 30 Wand progressively increased by 30 
W every 3 minutes until each subject reached a state of exhaustion. 
A gelatin capsule containing caffeine in a 5 mg/kg body weight dose 
was ingested for the caffeine trial. A gelatin capsule without added 
caffeine was ingested for the placebo trial. All subjects were blind-
folded prior to the administration of each capsule. Heart rates were 
recorded during the last 30 seconds of each workload. No significant 
differences were found for heart rate values between treatments at any 
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point during exercise. 
Gordon et al. (14) examined the effects of caffeine ingestion on 
submaximal cardiovascular function during a prolonged exercise bout. 
Ten males (19.4±1.5 years) participating in a physical instructors train-
ing course served as subjects. Subjects were randomly assigned to a 
caffeine group or a control group, with five subjects per group. Exer-
cise consisted of one hour and 40 minutes of continuous running on a 
motorized treadmill at an intensity equal to 70% of the subject's 
V02max. Caffeine (5 mg/kg body weight dissolved in 250 ml of an arti-
ficially sweetened orange drink) was ingested one hour prior to the 
exercise bout. The placebo solution was the same as the caffeine solu-
t ion, except that no caffei ne was added. Hea rt rates Here recorded 
at the cessation of exercise only. Mean heart rate for the caffeine 
group was 171±9 beats/min. The control group exhibited a mean heart 
rate of 165±4 beats/min. The differences in mean heart rates between 
the groups were not statistically significant. In addition, electro-
cardiographic activity for each subject was monitored in order to de-
termine the presence of arrhythmias during prolonged exercise as af-
fected by caffeine. The procedure used involved six standard leads 
(I, II, III, AVR, AVL, AVF) and two precordial leads (VI and V5). 
Although no arrhythmias were observed, the authors concluded that the 
age and physical fitness levels of the subjects used in this investiga-
tion may not be completely indicative of normal exercise ECG responses 
as influenced by caffeine in other subjects. Further research was speci-
fied on ECG responses following caffeine ingestion in individuals 
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suffering from ischemic heart disease, hypertension, and other cardio-
vascular abnormalities. 
Evidence has been presented and documented that an increase in 
body core temperature coupled with excessive loss of fluid during pro-
longed exercise may act as a detriment to peak performance. Core tem-
peratures in excess of 40°C and fluid losses exceeding 6-10% total body 
. 
weight have been reported following exercise longer than 1-2 hours dura-
tion (1). Although these are generally extreme cases, core temperature 
readings of 40°C and fluid losses equivalent to 3-5% of total body 
weight are commonly found in endurance exercise participants. The re-
sultant dehydration and thermal stress' may not only impair exercise 
performance, but may also endanger physical health through a reduction 
in sweat rate, reduction in total circulatory function, and disturbances 
in cardiac function and electrolyte balance. In addition, the induce-
ment of diuresis before and/or during exercise may contribute to de-
hydration during exercise, so that normal thermoregulatory functions 
are further disrupted (6, 13). 
As a known diuretic agent and thermoregulatory stimulant, it is 
possible that the use of a caffeinated substance during prolonged exer-
cise may actually impair rather than enhance exercise performance. 
However, few data are presently available to provide evidence of the 
effects of caffeine on thermoregulation and exercise performance. 
In a previously mentioned investigation by Van Handel et ale in 
which various physiological functions were monitored in subjects at 
rest following caffeine ingestion, it was stated that possible 
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caffeine-mediated effects on changes in body fluids and core tempera-
ture may significantly compromise thermoregulatory functions during 
prolonged exercise. The ingestion of a 150 mg caffeine solution in 
this study produced a significant diuresis, but no change in core tem-
perature as compared to lesser caffeine dosages. These results prompted 
the authors to recommend further study with a specific focus on thermo-
regulation as influenced by caffeine ingestion during prolonged exer-
cise. 
In a forementioned article, Gordon et ale examined the effects 
of caffeine ingestion on thermoregulation in 10 male subjects during 
a one hour 40 minute run on a treadmill. A blood sample was drawn prior 
to the exercise bout and two minutes before the end of the exercise 
bout to determine changes in electrolytes (Na+, K+, Cl-, Ca++, Mg++). 
Hemoglobin and hematocrit were calculated from the samples to determine 
percentage changes in plasma volume. Subjects were weighed prior to 
and following exercise, and a water deficit value (based on change in 
weight) was calculated. No significant differences existed for water 
deficit, percent change in plasma volume, or rectal temperatures (mea-
sured during exercise) between the caffeine and control groups. How-
ever, tile authors indicated the need for further research on caffeine 
and exercise thermoregulation by using greater caffeine dosages. 
In summary, the following statements may be drawn: an array of 
conflicting data exists on the issue of changes in cardiac function 
as influenced by caffeine during both resting and exercising conditions; 
observed caffeine effects on the cardiovascular system appear to be 
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largely dose-related; the effects of caffeine on thermoregulation during 
exercise have not been thoroughly investigated. Although it is beyond 
the scope of the present investigative endeavor to review all literature 
on the problem as stated, each source was chosen with the belief that 
it provided valid representation of the currently available data. 
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SECTION I. THE EFFECT OF CAFFEINE INGESTION ON 
CARDIOVASCULAR FUNCTION DURING MAXIMAL AND SUBMAXIMAL EXERCISE 
25 
I NTRODUCTI ON 
The effect of caffeine on the physiological responses to exercise 
has been widely studied from its possible influential role on metabolic 
substrate utilization during a prolonged exercise bout (9, 21, 26, 30). 
Caffeine has been shown to increase plasma free fatty acid levels in 
resting man (3, 18, 31) as well as increase fat metabolism during sub-
maximal exercise (9, 21, 26). It has been demonstrated that an increase 
in fat metabolism has a sparing effect on the use of muscle glycogen 
for substrate during prolonged exercise and may, therefore, enhance exer-
cise performance (9, 21). In contrast, other investigations have not 
found improvement in exerci se performance with caffei ne ingest ion (25, 
30) . 
Limited data are available as to the effects of caffeine on cardio-
vascular function during maximal and submaximal exercise. Resting heart 
rate and electrocardiographic activity may be altered through the direct 
stimulation of cardiac tissue by caffeine (3, 4, 5, 13, 18, 22, 28). 
Cardiac muscle stimulation and various influences on vasomotor tone due 
to caffeine ingestion have been shown to alter resting blood pressure 
(18,22,27). 
Heart rate has generally been the only cardiovascular parameter 
studied during prolonged exercise. Costill et ale (9), Gordon et al. 
(17), and Perkins and Williams (25) found no change in heart rate during 
exercise following the ingestion of caffeine~ Maximal heart rate has 
been shown to either increase (26, 30) or not change (25) v/ith tile use 
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of caffeine. Blood pressure response during maximal and submaximal 
exercise due to caffeine ingestion have not been reported. In addition, 
Gordon et al. (17) found no electrocardiographic abnormalities during 
submaximal exercise following the ingestion of caffeine. 
The purpose of this study was to assess the effect of caffeine in-
gestion on cardiorespiratory function during maximal and submaximal exer-
cise. 
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~lETHODS 
Subjects 
Six untrained males (21-28 years) volunteered as subjects for this 
experiment. All subjects were either students at Iowa State University 
or nonstudent members of the Ames, Iowa community. Each subject was 
informed of the risks and stresses associated with this study and gave 
their written consent. Subjects were asked to report to each exercise 
trial in a 12-hour fasted state. In addition, a 48-hour abstinence from 
any caffeine-containing product and a consistent dietary pattern 24 hours 
prior to all exercise trials were· required of each subject. 
Exercise Regimens 
Exercise regimens used in this investigation consisted of both a 
maximal and submaximal protocol. Two separate trials were conducted 
for each protocol, with one trial designated as the control treatment 
(decaffeinated) and one trial designated as the experimental treatment 
(caffeine). The order of treatments was randomly assigned in a double-
blind design. r,laximal exercise bouts were performed on a I'lonark bicycle 
ergometer with the workload increasing in a progressive step-wise man-
ner. RPM was set at 60. The initial pedal resistance was set at 0 kp 
for 4 minutes, increased to 1 kp for two minutes, and increased by .5 
kp every two minutes thereafter until exhuastion. Exhaustion was deter-
mined as the point at which the pedalling rate could no longer be main-
tained. Submaximal exercise bouts were also conducted on a Monark bi-
cycle ergometer. The protocol consisted of 90 minutes of continuous 
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exercise at 60% of the subject's maximal oxygen consumption. Cycling 
speed was also set at 60 RPM. 
One hour prior to the caffeine treatment for both the submaximal 
and maximal work bouts, each subject ingested 390 mg of caffeine citrate 
dissolved in 18 oz. of decaffeinated cola. An additional 65 mg of caf-
feine dissolved in 6 oz. of decaffeinated cola was administered immedi-
ately prior to exercise for both the submaximal and maximal bouts. Dur-
ing the 90-minute submaximal exercise bout, an additional 65 mg caffeine 
in 6 oz. decaffeinated cola was ingested at 15 minute intervals. Total 
caffeine dosage ingested was 455 mg for the maximal exercise bout and 
780 mg for the submaximal exercise bout. The solution for the decaf-
feinated control treatment for both maximal and submaximal exercise was 
administered by repeating the same protocol used for the caffeine treat-
ment minus the caffeine. 
Analytical Methods 
Oxygen consumption was determined by using an automated open circuit 
method. Expired oxygen and carbon dioxide concentrations were measured 
with an Applied Electrochemistry 5-3A analyzer and a Beckman LB-2 ana-
lyzer, respectively. Both analyzers were calibrated with known gas con-
centrations prior to each exercise treatment. Inspired air volume was 
measured with a calibrated Pneumoscan 5-301 spirometer. Room temperature 
for each treatment was maintained at 21°C and relative humidity ranged 
from 35-50%. Maximal values for minute ventilation (V E), oxygen consump-
. 
tion (V02), and respiratory rate (RR) for the maximal exercise bouts \vere 
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recorded as the highest value observed for each measure during exercise. 
Respiratory values in the submaximal bouts were recorded for Ve, V02, 
and respiratory exchange ratio (RER) immediately prior to exercise and 
at 10, 30, 60, and 90 minutes of exercise. Heart rate (HR), blood pres-
sure (BP), and a standard 12-lead electrocardiogram (ECG) were recorded 
prior to fluid ingestion, immediately prior to exercise, at the end of 
each workload, and immediately following the cessation of exercise in 
the maximal exercise bouts. During the submaximal bouts, HR, BP, and 
ECG were recorded prior to fluid ingestion, immediately prior to exer-
ci se, and at 10, 30, 60, and 90 mi nutes of exerci see Heart rate and 
ECG were monitored using an International Medical Corp. Viagraph. 
Statistical Analysis 
Haxi ma 1 values for V02, Ve, and RER \'/ere analyzed by a t-test pro-
cedure applied to differences between treatments for each variable. 
Data for rate pressure product (RPP=[HRmax XSBPmax]tl00) were also ana-
lyzed by a t-test procedure. Data for HR, BP, Ve, V02, and RER recorded 
in the submaximal exercise bouts were analyzed \,/ith a split-plot analysis 
of variance procedure to determine significant interaction between treat-
ment and time. If significant interaction was found, further clarifica-
tion of the interaction was determined by performing t-tests of the time 
period means between treatments. The .05 level of probability was chosen 
to determine significant results. 
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RESULTS 
Data for heart rate (HR) and blood pressure (BP) response (mean ± 
S.E.) during maximal exercise for both treatments are summarized in Table 
1. Pre-fluid heart rate for the caffeine treatment (7S.3 ± 3.S beats/ 
min) was 6.7% higher (p > O.OS) than the decaffeinated pre-fluid heart 
rate (70.3 ± 3.S beats/min). Heart rate measurements taken one hour 
post-fluid ingestion exhibited a decrease for both treatments from pre-
fluid values, with a mean caffeine heart rate of 69.2 ± 3.S beats/min, 
which was 7.6% higher (p > O.OS) than the decaffeinated mean of 64.0 ± 
3.50 beats/min. Mean maximal heart rate for the caffeine treatment was 
4.1% higher (p > O.OS) than the decaffeinated treatment (196.3 ± 3.S 
beats/min to 188.3 ± 3.S beats/min, respectively). 
Blood pressure values (systolic/diastolic, mean ± S.E.) prior to 
fluid ingestion were 117.0 ± 4.8/77.3 ± 2.2 mmHg for the decaffeinated 
treatment and 116.7 ± 4.8/78.6 ± 2.2 mmHg for the caffeine treatment. 
Post-fluid blood pressures showed little change from pre-fluid measure-
ments for the decaffeinated treatment (117.3 ± 4.8/75.7 ± 2.2 mmHg) , 
but revealed a slight increase from pre-fluid values for the caffeine 
treatment (121.3 ± 4.8/80.0 ± 2.2 mmHg). However, this difference was 
not significant. Systolic blood pressure taken at maximal exercise was 
3.0% higher for the caffeine treatment (217.0 ± 4.8 mmHg) than the decaf-
feinated treatment (210.3 ± 4.8 mmHg). However, maximal diastolic pres-
sure was slightly higher for the decaffeinated treatment compared to 
the caffeine treatment. 
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Tabl e l. Mean (±SEN) for heart rate (HR) and blood pressure (SBP, DBP) 
values at rest- pre-fluid, rest- post-fluid and maximal 
exercise for caffeine (C) and decaffeinated (D) treatments 
Pre- Post- r1ax 
Variable Treatment fl uid fluid Exercise 
HR (b/min) D 70.3 64.0 188.3 
(±3.5) (±3.5) (±3.5) 
c 75.3 69.3 196.3 
(±3.5) (±3.5) (±3.5) 
S8P (mmHg) D 117.0 117.0 210.3 
(±4.8 ) (±4.8 ) (±4.8) 
C 116.7 121.3 217.0 
(±4.8 ) (±4.8) (±4.8) 
DBP (mrnHg) D 77 .3 75.7 83.0 
(±2.3 ) (±2.3 ) (±2.3) 
C 78.6 80.0 82.4 
(±2.3 ) (±2.3 ) (±2.3) 
32 
As in the heart rate measurements, differences between treatments 
in blood pressure values were not found to be statistically (p > 0.05) 
significant at any of the observation periods. Rate pressure product 
(RPP=[HRmax X SBPmax]tl00) was also calculated as an indicator of cardiac 
work at maxi~al exercise. RPP was 7.0% higher (p > 0.05) for the caf-
feine treatment (426) as compared to the decaffeinated treatment (396). 
Data for oxygen consumption (V02max), minute ventilation (Vemax), 
and respiratory rate (RRmax) at maximal exercise for both treatments 
are summarized in Table 2. Maximal V02 was slightly higher for the caf-
feine treatment (49.1 ± 1.5 ml.kg-1.min-1) wilen compared to the decaf-
feinated treatment (48.6 ± 1.5 ml.kg-1.min-1) although the difference 
was not significant (p > 0.05). No statistical (p > 0.05) difference 
was found between treatments for Vemax, although the mean value for the 
caffeine treatment (131.0 ± 6.9 L/min) was slightly higher than the de-
caffeinated treatment (129.9 ± 6.9 L/min). Maximal RR for the caffeine 
treatment (51.6 ± 1.4 breaths/min) was 9.0% higher (p > 0.05) than the 
decaffeinated treatment (47.0 ± 1.4 breaths/min). 
Data for cardiovascular and respiratory function during submaximal 
exercise are summarized in Tables 3-4 and Figures 1-5. Pre-fluid HR 
values were similar between caffeine (68.7 ± 5.2 beats/min) and decaf-
feinated (68.8 ± 5.2 beats/min) treatments. Similar HR values for both 
treatments were also observed immediately prior to exercise. Throughout 
the 90 minute exercise bout, HR values were slightly higher at all mea-
surement periods for the caffeine treatment when compared to the decaf-
feinated treatment (Table 3, Figure 1). Mean exercise HR was 4.3% 
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Table 2. M~an (±SEM) for oxygen consumption (V02) and minute ventilation 
(Ve) value at maximal exercise for the caffeine (C) and the 
decaffeinated treatment 
Variable Treatment r~ax Exerci se 
. 
V02 (ml·Kg-l.min-1) D 48.8 (±1.5 ) 
C 49.1 (±1. 5) 
Ve (L/min) 0 129.9 (±6.9) 
C 131.0 (±6.9) 
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for the caffeine and decaffeinated trials 
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higher for the caffeine treatment (163.3 ± 5.2 beats/min) when compared 
to the decaffeinated treatment mean (156.3 ± 5.2 beats/min). Results 
similar to HR response were observed for both systolic and diastolic 
BP during exercise, with BP values higher in the caffeine treatment. 
Both systolic and diastolic BP decreased slightly from pre-fluid to pre-
exercise values in the decaffeinated treatment while BP remained rela-
tively stable during the same period in the caffeine treatment (Table 
3, Figure 2). Mean exercise systolic and diastolic BP were 7.4% and 
4.1% higher, respectively, for the caffeine treatment when compared to 
the decaffeinated treatment. Differences between treatment means for 
HR and BP were not significant (p > 0.05). 
Oxygen consumption values were higher for the caffeine trial at 
all measurement periods (Table 4, Figure 3). Mean exercise V0 2 was 8.0% 
higher for the caffeine treatment (32.6 ± 0.9 ml·kg-1·min-1) when com-
pared to the decaffeinated treatment (30.4 ± 0.9 ml.kg-1·min-1). Similar 
results were observed for minute ventilation (V E) Table 4, Figure 4). A 
9.0% increase in mean exercise VE was seen in the caffeine treatment 
(46.6 ± 1.8 L/min) when compared to the decaffeinated treatment (42.4 ± 
1.8 L/min). Neither of the above differences were statistically sig-
nificant (p > 0.05). In addition, no significant (p > 0.05) differences 
were observed between treatments for mean exercise respiratory exchange 
ratio (RER). Evaluation of electrocardiogram (ECG) tracings during both 
maximal and submaximal exercise bouts did not reveal the presence of 
any abnormal ECG recordings for either treatment. 
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DISCUSSION 
The results of this investigation did not reveal any statistically 
significant effects of caffeine ingestion on selected cardiovascular 
and respiratory functions during maximal and submaximal exercise. How-
ever, there was a definite trend across all subjects. Findings on maxi-
mal HR are in agreement with the 'vlork of Perkins and Williams (25), who, 
using a similar protocol, found no difference in maximal HR between caf-
feine and placebo trials. However, Toner et ale (30) demonstrated a 
significant elevation in maximal HR when 350 mg caffeine was ingested. 
It has been shown that ingestion of· caffeine will cause an elevation 
in resting HR through direct stimulation of the myocardium and through 
the effects of norepinephrine on cardiac muscle as a result of enhanced 
sympathetic discharge (20,21). Tachycardia is especially present when 
the caffeine dose is in excess of 200 mg (22). Robinson et ale (29) 
indicated that the sympathetic system is the only nervous input regu-
lating the heart during maximal intensity. Therefore, the 4.1% elevation 
in HR during maximal exercise following caffeine ingestion in the present 
study seems to be mediated through an enhanced sympathetic discharge. 
Considering the caffeine dosage used in the present investigation for 
the maximal exercise trial (455 mg) an elevation in maximal HR above 
decaffeinated control values would be expected. 
Toner et ale (30) reported no significant difference in HR during 
submaximal workloads following caffeine ingestion. However, three out 
of eight subjects did exhibit an increased HR with caffeine. In the 
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present study, a 4.3% increase in mean exercise HR was observed with 
the ingestion of caffeine. Although this increase was not statistically 
significant, all subjects showed a similar HR response. Since Toner 
et al. did not observe a significant elevation in HR during submaximal 
exercise following caffeine ingestion, it was suggested that during sub-
maximal exercise caffeine may enhance both parasympathetic and sympa-
thet i c di scha rge. Due to the fact that all subj ects in the present i n-
vestigation exhibited an elevated HR following caffeine ingestion, it 
vlOul d appear that sympathet i c activity overri des parasympathet i c act i vity 
during submaximal exercise. 
Data for both maximal and submaximal BP revealed no significant 
difference between caffeine and decaffeinated treatments. Little in-
formation is available on the specific effects of caffeine on BP during 
exercise. However, it has been shown that caffeine ingestion produces 
antagoni st i c effects on the vascul ar system. Di 1 at i on of coronary, pul-
monary, and systemic blood vessels by direct action on the vascular mus-
culature favor a decrease in BP, whereas, constriction of blood vessels 
through stimulation of the medullary vasomotor center and direct myo-
cardial stimulation favor an increase in BP (27). Based upon the results 
of this study, it appears that the effects of caffeine on BP responses 
during exercise parallel heart rate responses to caffeine ingestion as 
previously explained. Although it has been shown that caffeine may act 
to reduce vasoconstriction and increase muscle blood flow since both 
caffeine and epinephrine, which is elevated by caffeine, act to reduce 
peripheral resistance (3,4, 15,20, 30), the slight increases in BP 
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observed in the present study may be due to increased cardiac output 
as a result of elevated HR. 
The effect of caffei ne on V02max is not well documented. Toner 
et al. (30) found a small but significant increase in V02max following 
the ingestion of 350 mg of caffeine. In contrast, Ganslen et al. (16) 
have shown that 200 mg of caffeine did not increase V02max in one subject 
. 
during treadmill running. Margaria et al. (23) showed that V02max during 
treadmill running was not altered after 100 or 250 mg in three subjects. 
Results of the present study agree \-lith the findings of Ganslen et al. 
and Margaria et al. Submaximal V02 did not differ significantly between 
the caffeine and the decaffeinated trials. This also is in agreement 
with the findings of Costill et al. (9), Ivy et ale (21), and Toner et 
al. (30). Although the difference in V02 between treatments was not 
statistically significant for the submaximal exercise, all subjects 
. 
showed a consistently higher (mean 8.0%) V02 during the caffeine trial. 
Two possible reasons for an increase in oxygen consumption may be related 
to the elevated HR observed during the caffeine trial and the possibility 
of an increase in stroke volume as reported by Grollman (19) \vhich vlOuld 
have an effect on increasing cardiac output • 
. 
Minute ventilation (Ve) during maximal and submaximal exercise and 
respiratory rate (RR) during maximal exercise are not in agreement vJith 
previous research. Ganslen et ale (16) found a significant increase 
in Ve and RR both at rest and during maximal exercise following caffeine 
ingestion. Caffeine is known as having the strongest effect of all xan-
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xanthines as a respiratory stimulant (27). In the present study, caf-
feine did, in fact, appear to have some effect on respiratory stimulation 
as Ve and RR values were consistently higher (though not significant) 
during the caffeine trial. 
Respi ratory exchange rati 0 (RER) di d not respond as expected \'1hen 
caffeine was ingested before and during the submaximal exercise bout. 
The use of caffeine has been shown to increase fat oxidation for energy 
utilization by stimulating free fatty acid release (9,21). An increase 
in fat utilization is usually characterized by a lO~/er RER value, as 
compared to an increase in carbohydrate utilization, due to the greater 
volume of C02 produced relative to the volume of 02 consumed when fatty 
acid is oxidized (20). Based on the respiratory exchange ratio observed 
in this study, an increase in fat oxidation due to the ingestion of caf-
feine was not demonstrated as RER did not differ between trials. In 
fact, RER values were slightly higher over the course of the gO-minute 
exercise bout for the caffeine treatment. Fox and Mathews (15) reported 
that an increase in ventilation during exercise will result in an excess 
of C02 in expired air. It was previously mentioned that the ingestion 
of caffeine elevated both RR and Ve values as compared to the decaffein-
ated treatment. The increased ventilatory drive along with the increase 
. 
in VC02 when caffeine was ingested may have masked any change in RER 
as an indicator of substrate utilization during exercise. It should 
be noted that plasma concentrations of free fatty acids or glucose were 
not measured. 
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In summary, these data indicate that 445 mg of caffeine ingested 
prior to a maximal exercise bout and 780 mg of caffeine ingested prior 
to and during a submaximal exercise bout does not have a statistically 
significant effect on heart rate, systolic and diastolic blood pressure, 
minute ventilation, or oxygen consumption. However, there appears to 
be a consistent trend across all measures that warrants further investi-
gation. 
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SECTION II. THE EFFECT OF CAFFEINE INGESTION ON 
THERMOREGULATORY FUNCTION DURING SUBMAXIMAL EXERCISE 
51 
INTRODUCTION 
Caffeine has been widely studied as a possible ergogenic aid to 
exercise performance through its sparing effect on muscle glycogen. 
During prolonged exercise, caffeine has been shown to enhance fat metab-
olism and retard the depletion of muscle glycogen stores (3, 8, 11). 
The depletion of glycogen has been indicated as a detriment to exercise 
performance (1, 3, 8). However, data on the physiological effects of 
caffeine during exercise have been somewhat limited, focusing primarily 
on its role in substrate utilization and its influence on selected cardio-
respiratory parameters (heart rate, oxygen consumption, ventilatory 
rate). Though not widely investigated, caffeine may playa role in ther-
moregulatory processes at rest by stimulating metabolic heat production 
(7, 9, 16), inducing diuresis (15), and affecting gastric fluid emptying 
time (10). It has been speculated that some combination of these 
caffeine-influenced thermoregulatory effects could possibly reduce en-
durance exercise performance (hyperthermia, etc.), especially when ex-
posed to a hot humid environment (5, 15). 
Various studies have investigated physiological responses during 
exercise with regard to altered thermoregulatory function. Claremont 
et ale (2) found a significant reduction in both submaximal exercise 
performance and heat tolerance following a drug-induced diuresis. De-
creased cardiac output during submaximal exercise and decreased work 
time during maximal exercise follo\'ling thermal stress-induced dehydration 
were reported by Saltin (13). A state of dehydration induced by with-
holding fluids during exercise significantly elevated rectal and mean 
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body temperatures and reduced sweat loss in an investigation by Ekblom 
et ale (4). However, few data are available on the subject of caffeine-
mediated thermoregulatory control during exercise. In one of the few 
such investigations reported to date, Gordon et ale (5) found no signifi-
cant changes with the ingestion of caffeine in rectal temperature, plasma 
volume, or plasma-electrolytes (Na+, K+, Cl-, Ca2+, Mg2+) following a 
two hour run. The purpose of this study was to assess the effect of 
caffeine ingestion on thermoregulatory function during a submaximal exer-
cise bout. 
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~lETHODS 
Subjects 
Six untrained males (21-28 years) volunteered as subjects for this 
experiment. All subjects were either students at Iowa State University 
or nonstudent members of the Ames, I o \,1 a , community. Each subject was 
informed of the risks and stresses associated with this study and gave 
their written consent. Subjects were asked to report to each exercise 
trial in a 12-hour fasted state. In addition, a 48-hour abstinence from 
any caffeine-containing products and a consistent dietary pattern, 24 
hours prior to each exercise trial, were required of each subject. 
Exercise Regimen 
The exercise regimen used in this investigation was a submaximal 
protocol consisting of 90 minutes of continuous exercise on a Monark 
bicycle ergometer. Cycling speed was set at 60 RPM. Exercise intensity 
was set at 60% of the subject's measured maximal oxygen consumption. 
T\,lo exercise trials \'/ere performed, with one trial designated as the 
caffeine experimental treatment and one trial as the decaffeinated con-
trol treatment. 
One hour prior to the caffeine treatment, each subject ingested 
390 mg caffeine citrate dissolved in 18 oz. decaffeinated cola. Addi-
tional caffeine dosages of 65 mg caffeine citrate dissolved in 6 oz. de-
caffeinated cola were ingested immediately prior to exercise and at 15 
minute intervals during the exercise bout. Total caffeine dosage in-
gested by each subject was 780 mg. The solution for the decaffeinated 
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treatment \'ias admi ni stered by repeat i ng the same protocol used for the 
caffeine treatment minus the caffeine. 
Analytical Methods 
Oxygen consumption (V02) was determined by using an automated open 
circuit method. Expired oxygen and carbon dioxide concentrations were 
measured with an Applied Electrochemistry S-3A analyzer and a Beckman 
LB-2 analyzer, respectively. Both analyzers were calibrated with known 
concentrations prior to each exercise trial. Room temperature for each 
trial was maintained at 2l oC and relative humidity ranged from 35-50%. 
Oxygen consumption values were recorded immediately prior to exercise, 
and at 10, 30, 60, and 90 minutes of exercise. Heart rate (HR) was mon-
itored using an International Medical Corp. Viagraph at rest- pre-fluid 
ingestion, rest- pre-exercise, and at 10, 30, 60, and 90 minutes of exer-
cise. 
Skin temperature was monitored with surface electrodes placed on 
the thigh, forearm, forehead, and trunk. Core temperature (TREC) was 
monitored with a rectal probe inserted prior to testing. All tempera-
tures were recorded at rest pre-fluid, rest- pre-exercise, and 10, 30, 
60, and 90 minutes of exercise. ~lean skin temperature (TSKItI) and mean 
body temperature (TBODY) \'/ere calculated using the follO\'ling forr,lulas 
as reported by Saltin (13): 
TSKIrI = TTHIGH (.39) + TTRUNK (.35) + TAR~l (.19) + THEAD (.07) 
TBODY = TSKIN (.33) + TREe (.67) 
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A 5cc blood sample was taken at rest pre-fluid, rest pre-exercise, 
and 10, 30, 60, and 90 minutes of exercise. Blood samples were analyzed 
for hemoglobin (Hb), hematocrit (Hct), and serum electrolytes (Na+ and 
K+). Electrolytes were determined with a Unicam Atomic SP-90 Absorption 
Spectrophotometer. Pre- and post-exercise urine (UR) samples were col-
lected and measured for total urine volume for each subject. Pre-
exercise urine samples were collected for a period following the initial 
resting fluid ingestion to immediately preceding exercise. Post-exercise 
urine samples were collected for a 20-minute period following the cessa-
tion of exercise. Each subject was instructed to void all urine immedi-
ately prior to the initial fluid ingestion. Body weight \'las determined 
prior to the initial fluid ingestion after voiding, and immediately fol-
lowing post-exercise urine collection. 
Statistical Analysis 
Urine volume was analyzed by a t-test procedure applied to differ-
ences between treatments. Data for body weight (BW) taken at pre- and 
post-exerci se, and for V02, HR, TBODY, TREC, HEt,10, HCT, Na+, and K+ taken 
prior to ?nd during exercise were analyzed with a split-plot analysis 
of variance procedure to determine significant interactions between treat-
ment and time. If significant interaction was found, further clarifi-
cation of the interaction was determined by performing t-tests of the 
individual time period means between treatments. The .05 level of proba-
bility was chosen to determine significant results. 
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RESULTS 
Table 1 and Figures 1 and 2 depict mean (±SE) values for TBODY and 
TREC for the caffeine and decaffeinated treatments. No significant (p > 
0.05) differences were observed between treatments at rest or during 
exercise for either variable. Mean exercise values for TBODY were 36.3 
± O.loC for the caffeine treatment and 36.1 ± O.lOC for the decaffeinated 
treatment. Mean TREC values during exercise were 37.6 ± O.loC for the 
caffeine treatment and 37.4 ± O.lOC for the decaffeinated treatment. 
Serum electrolyte levels of Na+ and K+ (Table 2, Figures 3 and 4) 
increased slightly above resting values during exercise in both the caf-
feine and decaffeinated treatment, though the changes were not statisti-
cally significant (p > 0.05). Differences between treatments for both 
Na+ and K+ ,(Iere not significant (p > 0.05) at any point, with mean exer-
cise Na+ values of 144.7 ± 1.2 meq/l and 145.3 ± 1.2 meq/1 for the caf-
feine and decaffeinated treatments, respectively. Mean exercise values 
for K+ were identical for both treatments at 5.0 ± 0.5 meq/l. It did 
appear that serum levels of K+ increased at a slightly greater rate 
in the caffeine treatment as exercise progressed from the 10 minute to 
the 90 minute period. 
Data for Hb (Table 3, Figure 5) exhibited a mean (±SE) exercise 
value 2.3% higher in the caffeine treatment (17.2 ± 0.3 gm) when compared 
to the decaffeinated treatment (16.8 ± 0.3 gm). However, the difference 
was not statistically significant (p > 0.05). Mean (±SE) Hct (Table 3, 
Figure 6) showed a similar response to Hb, with Hct 1.3% higher during 
exercise in the caffeine treatment when compared to the decaffeinated 
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treatment. However, no significance (p > 0.05) was found between treat-
ments. 
Heart rates (Figure 7) did not differ significantly (p > 0.05) be-
tween treatments although the mean exercise value was 4.2% higher for 
the caffeine treatment. Changes in body weight (Figure 8) did not differ 
(p > 0.05) from pre-exercise to post-exercise for either treatment nor 
were they significant at any measurement period between treatments. 
Despite the lack of statistical support for a caffeine-induced fluid 
volume change as evidenced by hemodynamic and body 'v'leight data, urine 
volume was 21.2% higher in the caffeine treatment (264.1 ml) as compared 
to the decaffeinated treatment (208.6 ml). However, the difference be-
tween treatments was not significant (p > 0.05). 
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DISCUSSION 
Based on the results of this investigation, the ingestion of caf-
feine had no statistically significant effect on thermoregulatory con-
trol during submaximal exercise. However, a definite trend existed 
across all subjects. As previously indicated, little information is 
available on the specific effects of caffeine on thermoregulation during 
exercise. It has been shown that caffeine ingestion at rest is capable 
of stimulating increases in metabolic heat production and core tempera-
ture (7, 9, 16), and inducing diuresis (15). Increases in heat produc-
tion occur in part due to the stimulatory effects of enhanced epinephrine 
release by caffeine on the thermoregulatory centers of the hypothalamus 
(12). In addition, caffeine has a direct affect on the renal tubular 
system so that glomerular filtration rate is increased and Na+ reabsorp-
tion is decreased, leading to a diuretic effect (6). 
Results for core temperature and changes in hemodynamic constituents 
(HEMO and HCT) are in agreement with the work of Gordon et ale (5), who 
found no differences in rectal temperature, percent change in plasma 
volume, or water deficit between caffeine and control trials following 
two hours of running at approximately 75% HR max. The authors suggested 
that the failure of caffeine to affect cardiac output (as evidenced by 
no change in HR between trials; stroke volume (SV) was not measured) 
would have a similar effect on renal blood flow before and during exer-
cise and would partially account for the lack of observed differences 
in water loss. It was also suggested that the known dilating effects 
of caffeine on peripheral vasculature should compensate for an increase 
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in metabolic heat production, in terms of blood flow distribution to 
the skin, therefore, helping to maintain core temperature. Finally, 
the authors indicated that the caffeine dosage required to elicit the 
above effects may be in excess of that used in their study (5 mg/kg body 
weight). In the present investigation, a caffeine dosage of 780 mg was 
ingested by each subject. An increase in exercise HR of 4.3% was ob-
served in the caffeine treatment, and UR volume was 21% higher with caf-
feine. In addition, core, skin, and body temperature, and HEMO and HCT 
values were consistently higher during exercise in the caffeine treat-
ment. Although these differences were not significant, it would appear 
that the caffeine dosage used in this study may have affected cardiac 
output and metabolic heat production sufficiently to evoke the observed 
results. 
It has also been demonstrated that a reduction in body fluids 
through either drug-induced diuresis or thermal dehydration will sig-
nificantly affect thermoregulation by reducing the circulatory response 
needed for metabolic heat dissipation and, therefore, augmenting the 
increase in core temperature normally observed during prolonged exercise 
when using a variety of protocols (2, 4, 13). Although the results were 
not significant, a 21~ mean increase in UR volume in the present investi-
gation with the ingestion of caffeine may cause one to expect a diuretic-
influenced effect on core and body temperatures. Although not statisti-
cally significant, all subjects did exhibit an increase in all tempera-
ture readings in the caffeine treatment. However, it should be noted 
that none of the subjects suffered from symptoms 
68 
of heat illness. 
There were no significant differences in serum electrolytes Na+ 
and K+ concentrations between treatments. This is in agreement with 
the forementioned study by Gordon et ale (5). These results are also 
similar to the work of Wilkerson (17) who, in a noncaffeine related 
study, found no change in plasma Na+ or K+ concentrations above control 
during different exercise durations (9 min, 14 min, 19 min), each con-
. 
ducted at 60% V02 max. Caffeine is known to directly affect the renal 
tubules so that Na+ reabsorption is decreased. An excessive loss of 
electrolytes during prolonged exercise, especially when associated with 
high rates of fluid loss, is kno~m to disturb normal homeostatic circu-
latory and nervous function (14). The Na+ and K+ help regulate the func-
tion of neuromuscular control. The trend observed in the present in-
vestigation regarding the loss of fluid between treatments might lead 
to a change in serum electrolyte concentrations. However, this did not 
appear to be true. It should be reported that UR volume samples were 
not assayed for Na+ or K+ content. A 1 so, the problem exi sts that the 
measurement of electrolyte concentrations relative to blood fluid volume 
may not be indicative of actual serum electrolyte content when change 
in blood fluid volume is not considered (17). Blood fluid volume changes 
were not measured in this investigation. 
In summary, these data indicate that 780 mg of caffeine ingested 
prior to and during a submaximal exercise bout does not have a statis-
tically significant effect on thermoregulatory control, as determined 
by core and body temperatures, urine loss, hemodynamic constituents (Hb 
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and Hct), and serum electrolytes (Na+ and K+). However, there appears 
to be a consistent trend across most of the parameters measured that 
warrants further investigation. 
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GENERAL SUMMARY 
This investigation was intended to assess the effects of caffeine 
ingestion on cardiovascular function (heart rate, blood pressure, electro-
cardiographic activity) during maximal and submaximal exercise and to 
determine the caffeine-mediated effects of thermoregulatory control dur-
ing submaximal exercise as determined by hemodynamic variables (hemo-
globin, hematocrit, serum electrolytes), fluid loss, and body tempera-
tures. Subjects used were six healthy untrained males ages 21-28. Maxi-
mal exercise was conducted using a step-wise protocol to V02max on a 
cycle ergometer. Submaximal exercise consisted of 90 minutes continuous 
work on a cycle ergometer at 60% V02max. All variables were monitored 
at regular intervals both prior to and during exercise. 
The results indicated that the ingestion of 455 mg caffeine in the 
maximal exercise trial and 780 mg caffeine in the submaximal trial failed 
to produce statistically significant changes in any of the cardiovascular 
or thermoregulatory parameters observed when compared to a control trial. 
However, a definite trend did appear to exist across a majority of the 
measures for all subjects. The observed trend, combined with a general 
lack of available data on the effects of caffeine on cardiovascular or 
thermoregulatory function during exercise, should warrant further investi-
gation. 
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